[
  {
    "ts": "2026-02-18T13:00:00+00:00",
    "headline": "Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics",
    "summary": "Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targetsSANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today announced a research collaboration and licensing agreement with Novartis on an undisclosed program. The collaboration brings together UNP’s AI-enhanced macrocycle platform and Novartis’ global develo",
    "url": "https://finance.yahoo.com/news/unnatural-products-announces-licensing-agreement-130000763.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "89a44827-c5bb-389a-acc0-2d04117b828a",
      "content": {
        "id": "89a44827-c5bb-389a-acc0-2d04117b828a",
        "contentType": "STORY",
        "title": "Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics",
        "description": "",
        "summary": "Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targetsSANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today announced a research collaboration and licensing agreement with Novartis on an undisclosed program. The collaboration brings together UNP’s AI-enhanced macrocycle platform and Novartis’ global develo",
        "pubDate": "2026-02-18T13:00:00Z",
        "displayTime": "2026-02-18T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/44f057fffd66decb55723e6448d7050b",
          "originalWidth": 1526,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lI4Q8xxGkQ5GDVo.6K3tDw--~B/aD02Njc7dz0xNTI2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/44f057fffd66decb55723e6448d7050b.cf.webp",
              "width": 1526,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zlukqT_TPuZiEkW56X6Bxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/44f057fffd66decb55723e6448d7050b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/unnatural-products-announces-licensing-agreement-130000763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/unnatural-products-announces-licensing-agreement-130000763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVS"
            },
            {
              "symbol": "UNP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]